Breakthrough vaccine targets tick-borne bovine anaplasmosis in cattle

University of Missouri researchers are working to develop the first-ever vaccine proven to protect cattle from a devastating tick-borne cattle disease known as bovine anaplasmosis.

Ozempic/Wegovy and 14 Other Drugs Selected for Medicare Price Negotiation

The blockbuster diabetes and weight-loss drug semaglutide (Ozempic, Rybelsus, Wegovy) along with therapies for asthma, cancers, and various other conditions were among the 15 drugs

January 18, 2025

Scratching found to both aggravate inflammation and boost immune defenses

New research uncovers the dual nature of scratching an itch; although it can worsen skin inflammation, it can also boost immune defenses against bacterial infections

January 31, 2025

Virpax plans three trials based on platform drug delivery systems in 2024

Patient recovering after surgery. Virpax is planning a Phase II trial in post-operative pain management around the end of H1 2024. Image Credit: Shutterstock /

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.